ASHLEIGH LEOPARD: Open Payments
NPI 1104277425 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 28 payments from 12 companies in 2025. Trend: 2023 $1,349 · 2024 $679 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $184 |
| Sumitomo Pharma America, Inc. | 6 | $155 |
| MERZ NORTH AMERICA, INC. | 1 | $108 |
| Medtronic, Inc. | 3 | $93 |
| Endo USA, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $44 |
| Boston Scientific Corporation | 1 | $41 |
| Olympus America Inc. | 1 | $40 |
| COLOPLAST CORP | 2 | $40 |
| Procept Biorobotics Corporation | 1 | $38 |
Products named: BOTOX, GEMTESA, Xeomin, INTERSTIM, AVEED, XTANDI, AMS 700, iTIND System.
Industry payments across SC — which companies pay providers there.
